logo
Texas banned abortions - and then sepsis rates started to soar

Texas banned abortions - and then sepsis rates started to soar

Yahoo20-02-2025
The rate of sepsis dramatically increased among pregnant women in Texas after the state's restrictive abortion laws took effect, according to a report.
ProPublica analyzed seven years of Texas hospitals' discharge data — from 2017 through 2023 — and found that since 2021, when the southern state's initial abortion ban went into effect, the rate of sepsis surged by more than 50 percent for women hospitalized when they experienced miscarriages in the second trimester.
Sepsis is a medical emergency that occurs when a patient's body improperly reacts to an infection. It can lead to organ failure or death if not treated quickly enough.
In September 2021, the state banned most abortions after a fetal heartbeat was detected. Then, in August 2022 following the Supreme Court's decision to overturn Roe v Wade, Texas's 'trigger law' took effect, criminalizing abortion. Doctors who perform abortions could face life in prison and fines of up to $100,000. Now, abortions are banned in all cases except if the mother's health or life is at risk — a definition that the state's supreme court has refused to clarify.
The rate of sepsis among patients experiencing second-trimester pregnancy loss remained pretty steady until the state added criminal penalties for abortion providers, the analysis shows.
In 2021, before they were introduced, 67 patients who miscarried in the second trimester were diagnosed with sepsis but after, in 2022, that figure increased to 90. That number increased again to 99 in 2023.
ProPublica believe those figures could be 'conservative.'
Treating miscarriages has also become complicated as a result of these laws. Medical professionals are constrained by either having to wait for the mother's life to be in jeopardy or having to wait for the fetus' heart to stop beating.
For example, three days after the fetal heartbeat law took effect, on September 3, 2021, Josseli Barnica went to a Houston hospital at 17 weeks pregnant to discover she was battling a deadly infection as a result of a miscarriage. But doctors were restricted in how they could treat her, since her fetus still had a heartbeat. After 40 hours in pain from the infection, Barnica delivered the fetus after there was no longer a detectable heartbeat. Three days after being treated and discharged, she died from sepsis. Medical experts who reviewed her case told ProPublica that they believed her death was 'preventable.'
Another patient cited in the study, Nevaeh Crain, died after doctors waited for her fetus' heart to stop beating as her organs failed. Before rushing the teenager to the operating theter, they conducted another test to confirm her fetus had expired, the outlet reported.
The data also underscores the confusion around miscarriage treatment. The rate of sepsis was less severe for pregnant patients who were admitted to the hospital without a fetal heartbeat. The rate moved from 2.1 percent in 2017 to 3.1 percent in 2023 for those admitted with fetal death, and from 3.7 percent to 6.9 percent for those without fetal death.
'What this says to me is that once a fetal death is diagnosed, doctors can appropriately take care of someone to prevent sepsis, but if the fetus still has a heartbeat, then they aren't able to act and the risk for maternal sepsis goes way up,' Dr. Kristina Adams Waldorf, professor of obstetrics and gynecology at UW Medicine, told the outlet. 'This is needlessly putting a woman's life in danger.'
Other indicators suggest pregnancy in Texas has become more dangerous. Since 2021, dozens more pregnant and postpartum women have died in Texas hospitals than had before the Covid-19 pandemic — despite a drop in maternal mortality rates at a national level in the same period.
There were 79 maternal hospital deaths in 2018 and 2019 compared to 2022 and 2023 when there were 120. Despite this alarming uptick, the Texas Maternal Mortality and Morbidity Review Committee opted not to review pregnancy-related deaths in 2022 and 2023.
'The fact that Texas is not reviewing those years does a disservice to the 120 individuals you identified who died inpatient and were pregnant,' said Dr. Jonas Swartz, an assistant professor of obstetrics and gynecology at Duke University. 'And that is an underestimation of the number of people who died.'
The laws in place appear to be interfering with patient care, one doctor suggested.
'We have the ability to intervene before these patients get sick,' Dr. Sarah Prager, a professor of obstetrics and gynecology at the University of Washington, told the outlet. 'This is evidence that we aren't doing that.'
Even though the Texas Supreme Court rejected a lawsuit asking for clarification over who qualifies for an abortion in the state, Lt. Gov. Dan Patrick called on the state legislature to clear up the language of the law. 'I do think we need to clarify any language so that doctors are not in fear of being penalized if they think the life of the mother is at risk,' he said last month.
Gov. Greg Abbott, however, doesn't seem to be convinced that any clarification is necessary. 'There have been hundreds of abortions that have been provided under this law, so there are plenty of doctors and plenty of mothers that have been able to get an abortion that saved their lives and protect their health and safety,' he told the Houston Chronicle this week before ProPublica's report was released. 'So I know as the law as it currently exists can work if it is properly applied.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gov't agency exposed for allowing drugs from dangerous foreign factories into the US: Report
Gov't agency exposed for allowing drugs from dangerous foreign factories into the US: Report

American Military News

time7 hours ago

  • American Military News

Gov't agency exposed for allowing drugs from dangerous foreign factories into the US: Report

A new report claims that the U.S. Food and Drug Administration secretly allowed substandard foreign factories with dangerous manufacturing issues to ship hundreds of medications to the United States despite being officially banned by the agency. In June, ProPublica reported that a group of individuals inside the Food and Drug Administration exempted drugs shipped to the U.S. from foreign factories despite the agency banning imports from certain factories due to contamination and other issues. The outlet noted that pills and other medications exempted from the bans were distributed to Americans and claimed that the agency did not regularly test the drugs for quality issues or track the medications to determine whether the medications were causing harm. According to ProPublica, Janet Woodcock, a former Food and Drug Administration employee, told the outlet, 'We felt we didn't have to make it a public thing.' READ MORE: Experimental vaccine may prevent recurrence of cancer In a new report, ProPublica claimed that the Food and Drug Administration did not adequately monitor various reports filed by medical providers and other individuals who warned that some drugs had a bad odor, residue, or abnormal taste. The outlet claimed that the government agency also did not adequately monitor reports of patients experiencing abnormal health issues potentially related to certain medications. According to ProPublica, the Food and Drug Administration largely withheld the information regarding the medication import ban exemptions from the American public and has not shared a list of medications that the U.S. government allowed into the country from foreign factories banned by the agency. However, ProPublica released a list of the drugs and ingredients that the outlet determined were exempted from import bans since 2013. The list also reveals the manufacturing companies responsible for the production of the medications. ProPublica reported that the news outlet found that the Food and Drug Administration exempted over 150 medications and ingredients from import bans. While the majority of the exempted products came from India, ProPublica reported that a Chinese factory and a Hungarian factory were also exempted by the federal agency.

Abortion pill fight reaches pharmacy board rooms
Abortion pill fight reaches pharmacy board rooms

Axios

time20 hours ago

  • Axios

Abortion pill fight reaches pharmacy board rooms

A year after the Supreme Court preserved abortion pill access, the fight over dispensing mifepristone is shifting from courtrooms to boardrooms as anti-abortion forces press pharmacy chains not to sell the drugs. The big picture: Costco last week said it won't stock mifepristone at its more than 500 pharmacies. Conservative groups are pushing other pharmacies — including Walgreens and CVS, which offer the pills in states where abortion is legal — to follow suit. "We can effectuate real change by talking to these companies and engaging with them," said Michael Ross, legal counsel for Alliance Defending Freedom's corporate engagement team. "Hopefully Costco will be a trendsetter." But those efforts are making retail pharmacies a new ground zero in the fight over abortion access. Costco got swift criticism from one of its home-state senators, Washington Democrat Patty Murray, for accommodating "far-right extremists" she said were whipsawing the availability of basic care. Between the lines: Pharmacy chains were destined to be involved after the Food and Drug Administration in 2023 allowed retailers to apply for certification to dispense mifepristone, which is part of a two-step protocol used to medically end a pregnancy through 10 weeks. The drug, which FDA first approved in 2000, has traditionally been dispensed at doctors' offices, hospitals or health clinics. But as states across the country restrict abortion, mifepristone prescribing via telehealth has significantly increased. State of play: Costco says it won't pursue approval to dispense mifepristone because demand for the drug is low. The company's understanding is that patients generally get the drug directly from their medical providers, it said in an email. But the decision, which reportedly came after more than a year of deliberations, is one anti-abortion groups have been pushing for. It extends beyond Costco's membership, since nonmembers can fill prescriptions at its drug counters. Last August, Alliance Defending Freedom led a coalition including thousands of Costco cardholders, financial advisers and consultants in urging the retailer not to offer mifepristone. "Costco ... needs to carefully consider the cost of alienating its diverse customers and potential customers just to boost one product in its pharmacy, which is one of its ancillary lines of business," their letter said. That pressure campaign followed New York City Comptroller Brad Lander (D) sending letters to Costco and other pharmacies, advocating that they get clearance to fill prescriptions where legal. "Making mifepristone available benefits customers and employees and increases sales, while also generating long-term shareholder value," Lander wrote to Costco last year. But abortion foes have allied with investor groups like Inspire Investing to warn Costco, Walmart, Albertsons, Kroger and other retail pharmacy operators as well as drug distributors to stay out of divisive political issues that could alienate customers and investors. "We say, OK, mifepristone may be a very small part of your sales, but look at all of the different backlash that you might be introducing, the different regulatory backlash from the Trump admin and the legal risk," Ross said. The Trump administration, Congress or the Supreme Court could still change requirements around the drug. The Supreme Court in 2024 preserved access to mifepristone, deciding that doctors who asked justices to stop the FDA's relaxation of restrictions around the drug didn't have standing, without ruling on the merits. In May, HHS Secretary Robert F. Kennedy Jr. said he'd directed the FDA to "to review the latest data on mifepristone" — a move that could restrict future availability. Other large pharmacy chains like Walmart, Kroger and Albertsons have not made public decisions on mifepristone dispensing. Kroger told Axios it's still reviewing the FDA's mifepristone drug safety program and will continue to align dispensing practices with federal and state law. Walmart declined to comment, and Albertsons did not respond. The other side: Curbing mifepristone access could make it even harder for women to access safe abortions, as well as miscarriage care, for which it has an off-label use. "By refusing to offer mifepristone, Costco has chosen politics over science, fear over facts, and ideology over the rights of its customers," Mini Timmaraju, CEO of advocacy group Reproductive Freedom for All, said in a statement last Friday. What we're watching: How Walgreens and CVS respond to pressure to stop filling mifepristone prescriptions.

Brazil's former president Bolsonaro temporarily leaves house arrest for medical exams

time3 days ago

Brazil's former president Bolsonaro temporarily leaves house arrest for medical exams

SAO PAULO -- SAO PAULO (AP) — Brazil's Former President Jair Bolsonaro temporarily left house arrest Saturday to undergo medical exams in Brasilia, after a judge authorized him to spend six to eight hours at a hospital. Doctors at DF Star hospital said Bolsonaro was admitted for evaluation of fever, cough, persistent gastroesophageal reflux and hiccups. Tests revealed residual signs of two recent pulmonary infections, as well as persistent esophagitis and gastritis. He was discharged later in the day and will continue treatment with medication. He has been hospitalized multiple times since being stabbed at a campaign event before the 2018 presidential election. His most recent surgery was in April, for a bowel obstruction. Bolsonaro is on trial at the Supreme Court over his alleged attempt to remain in power after losing the 2022 election to President Luiz Inácio Lula da Silva. A five-justice panel is expected to deliver verdicts and sentences on five counts against him between Sept. 2 and 12. Bolsonaro denies any wrongdoing. The far-right leader has been under house arrest since Aug. 5. Supreme Court Justice Alexandre de Moraes, who oversees the case, said Bolsonaro violated precautionary measures by spreading content through his three lawmaker sons. A small group of fewer than 20 people gathered outside DF Star hospital Saturday, claiming Bolsonaro is a victim of political persecution. Some thanked U.S. President Donald Trump, who has called the prosecution a 'witch hunt' and linked his decision to impose a 50% tariff on Brazilian imports to Bolsonaro's legal troubles. ___ Luís Nova contributed reporting in Brasilia. ___

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store